Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs01727736
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
AKN | (2R)-4-AMINO-N-{(1R,2S,3S,4R,5S)- 5-AMINO-2-[(3-AMINO-3-DEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-4-[(6-AMINO- 6-DEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]- 3-HYDROXYCYCLOHEXYL}-2-HYDROXYBUTANAMIDE | A,B | 2G5Q | 0.75 |  |
JS5 | A,B | 2BE0 | 0.73 | | |
KSG | (1S,2R,3S,4R,5S,6S)-2,3,4,5,6-PENTAHYDROXYCYCLOHEXYL 2- AMINO-4-{[CARBOXY(IMINO)METHYL]AMINO}- 2,3,4,6-TETRADEOXY-ALPHA-D-ARABINO- HEXOPYRANOSIDE | A | 1VS7 | 0.72 | |
| KSG | (1S,2R,3S,4R,5S,6S)-2,3,4,5,6-PENTAHYDROXYCYCLOHEXYL 2- AMINO-4-{[CARBOXY(IMINO)METHYL]AMINO}- 2,3,4,6-TETRADEOXY-ALPHA-D-ARABINO- HEXOPYRANOSIDE | A | 2HHH | 0.72 | |
| KSG | (1S,2R,3S,4R,5S,6S)-2,3,4,5,6-PENTAHYDROXYCYCLOHEXYL 2- AMINO-4-{[CARBOXY(IMINO)METHYL]AMINO}- 2,3,4,6-TETRADEOXY-ALPHA-D-ARABINO- HEXOPYRANOSIDE | A | 1VS5 | 0.72 | |
JS4 | A,B | 2BEE | 0.74 | | |
G0B | A | 2JUK | 0.82 | | |
GET | GENETICIN | A | 1MWL | 0.75 | |
| GET | GENETICIN | A,B,C,D | 1NJJ | 0.75 | |
GTH | 3-O-GLUCOPYRANOSYL-THREONINE-[2- DEOXY-2-ACETAMIDO-GLUCOPYRANOSIDE] | A | 1WCT | 0.73 | |
HYG | HYGROMYCIN B | A,E,N | 3DF1 | 0.73 | |
| HYG | HYGROMYCIN B | A,E | 3DF3 | 0.73 | |
| HYG | HYGROMYCIN B | A,D,H,N | 1HNZ | 0.73 | |
CNY | 13,15-DIAMINO-2-(AMINOMETHYL)-3,4,9,12- TETRAHYDROXYHEXADECAHYDRO-2H-7,10- EPOXYPYRANO[2,3-B][1,10,4]BENZODIOXAZACYCLODODECIN- 8-YL 2,6-DIAMINO-2,6-DIDEOXYHEXOPYRANOSIDE | A,C,D | 1ZZ5 | 0.75 | |
FSM | FORSMANN ANTIGEN | A | 2CGY | 0.7 | |
AS5 | 2-(acetylamino)-4-O-[2-(acetylamino)- 2-deoxy-alpha-L-gulopyranosyl]- 1,5-anhydro-2-deoxy-D-mannitol | A,B | 2VLC | 0.7 | |
A16 | 4-O-(4,6-dideoxy-4-{[(1S,2S,3S,4R,5S)- 2,3,4-trihydroxy-5-(hydroxymethyl)cyclohexyl]amino}- alpha-D-glucopyranosyl)-beta-D- glucopyranose | A,B | 2VR5 | 0.71 | |
MGU | 2-O-[2-O-METHYL-4-[2,4-DIHYDROXY- BUTYRAMIDO]-4,6-DIDEOXY-]-ALPHA- D-MANNOPYRANOSYL-[1-O-METHYL-4- [2,4-DIHYDROXY-BUTYRAMIDO]-4,6- DIDEOXY]-ALPHA-D-MANNOPYRANOSE | H | 1F4Y | 0.72 | |
AO3 | ALLOSAMIDIN | A | 1X6N | 0.71 | |
LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)- 4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO- 6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN- 2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)- 5-METHYL-4-(METHYLAMINO)-TETRAHYDRO- 2H-PYRAN-3,5-DIOL | 4,B | 2QBK | 0.75 | |
| LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)- 4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO- 6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN- 2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)- 5-METHYL-4-(METHYLAMINO)-TETRAHYDRO- 2H-PYRAN-3,5-DIOL | A | 2QBH | 0.75 | |
| LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)- 4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO- 6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN- 2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)- 5-METHYL-4-(METHYLAMINO)-TETRAHYDRO- 2H-PYRAN-3,5-DIOL | 4,B | 2QBI | 0.75 | |
| LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)- 4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO- 6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN- 2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)- 5-METHYL-4-(METHYLAMINO)-TETRAHYDRO- 2H-PYRAN-3,5-DIOL | A,B | 2ET3 | 0.75 | |
| LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)- 4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO- 6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN- 2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)- 5-METHYL-4-(METHYLAMINO)-TETRAHYDRO- 2H-PYRAN-3,5-DIOL | A,E | 2QBJ | 0.75 | |
| LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)- 4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO- 6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN- 2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)- 5-METHYL-4-(METHYLAMINO)-TETRAHYDRO- 2H-PYRAN-3,5-DIOL | A | 2QB9 | 0.75 | |
| LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)- 4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO- 6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN- 2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)- 5-METHYL-4-(METHYLAMINO)-TETRAHYDRO- 2H-PYRAN-3,5-DIOL | 4,B | 2QBC | 0.75 | |
| LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)- 4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO- 6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN- 2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)- 5-METHYL-4-(METHYLAMINO)-TETRAHYDRO- 2H-PYRAN-3,5-DIOL | 4,B | 2QBA | 0.75 | |
| LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)- 4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO- 6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN- 2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)- 5-METHYL-4-(METHYLAMINO)-TETRAHYDRO- 2H-PYRAN-3,5-DIOL | A,N | 2QBB | 0.75 | |
MMR | N-((2R,3R,4S,6S)-6-(HYDROXYMETHYL)- 2-METHOXY-4-((S)-1-OXOPROPAN-2- YLOXY)TETRAHYDRO-2H-PYRAN-3-YL)ETHANAMIDE | L | 2EAX | 0.7 | |
AB9 | (2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)- 5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}- 4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}- 2-HYDROXYBUTANAMIDE | A,D,M,N,Z | 2F4V | 0.75 | |
| AB9 | (2R)-4-AMINO-N-{(1R,2S,3R,4R,5S)- 5-AMINO-2-{2-[(2-AMINOETHYL)AMINO]ETHOXY}- 4-[(2,6-DIAMINO-2,6-DIDEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-3-HYDROXYCYCLOHEXYL}- 2-HYDROXYBUTANAMIDE | B | 2F4T | 0.75 | |
N30 | (1R,2R,3S,4R,6S)-4,6-DIAMINO-2- [(5-AMINO-5-DEOXY-BETA-D-RIBOFURANOSYL)OXY]- 3-HYDROXYCYCLOHEXYL 2-AMINO-2-DEOXY- ALPHA-D-GLUCOPYRANOSIDE | B | 2O3X | 0.71 | |
CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1LJN | 0.7 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1ZU0 | 0.7 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 2HRH | 0.7 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A,B | 1TW5 | 0.7 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A,H | 2HRG | 0.7 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | 1 | 2BS7 | 0.7 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1C7T | 0.7 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A,B | 2QT6 | 0.7 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1QBB | 0.7 | |
| CBS | DI(N-ACETYL-D-GLUCOSAMINE) | A | 1C7S | 0.7 | |
AB6 | (2R)-4-AMINO-N-((1R,2S,3R,4R,5S)- 5-AMINO-4-[(2-AMINO-2-DEOXY-ALPHA- D-GLUCOPYRANOSYL)OXY]-2-{2-[(3- AMINOPROPYL)AMINO]ETHOXY}-3-HYDROXYCYCLOHEXYL)- 2-HYDROXYBUTANAMIDE | B | 2F4U | 0.77 | |